Month: September 2022

THE FOUNDER'S DILEMMA. This thoughtful essay lays out the issues and known data points. Just beware of the Big Company Hired Gun who looks good on paper, but cannot adapt to a fast-moving organization where the data points for moving forward may not exist, and the budget does not include a BCG for every new strategic initiative. Changing a wrong CEO choice is a VERY time-consuming and precarious struggle that can endanger the entire company, So, do your reference checks with the uttermost care, and do not get bullied into an expedient wrong choice. http://lnkd.in/uv_F5D View in LinkedIn

BIG HEALTHCARE COMPANIES CONTINUED INTEREST IN EMERGING COMPANIES. Yes, empty pipelines and inefficient discovery programs make for this continuing trend and symbiotic relationship; and emerging companies need both the capital and the marketing muscle to continue to do what they do best: innovate cheaply. http://lnkd.in/qi6ZQb View in LinkedIn

MENTORS COUNT for early stage entrepreneurs, and can really make the difference between success and failure, if you choose carefully. Also, with the odds stacked against you (the oft quoted stat that 90% of VC investments fail). if that happens, be prepared. If you have the temperament, get back on that horse and learn from your first mistakes. Write an analysis of what worked and what did not. Share that with a mentor and discuss. This B-School Class is live! http://lnkd.in/TrDFQv View in LinkedIn

GREAT ADVICE EVERY ENTREPRENEUR MUST INTERNALIZE. These are the KEY questions to ask of a VC, period. You MUST get answers before you say yes to an investment. A wrong VC can wreck your company as quickly as no VC can. And remember, when you go for Series B, the VC investors you have selected will come under as much scrutiny as your company, and they can be a very fastidious bunch. http://lnkd.in/NfntTa View in LinkedIn

WILL WE DEVELOP A TWO TIERED HEALTHCARE WORLD? Inevitable downward price pressures from the developing world will obviously favor generic drugs, while the quest for better medicines will drive developed world innovation. How this plays out globally is a key issue for public health. http://social.eyeforpharma.com/market-access/patent-war-mncs-change-their-battle-strategy-india View in LinkedIn

DIAGNOSIS, EVEN WITHOUT TREATMENT IS VITAL FOR FAMILIES. Diseases like Batten Disease and Duchenne MuscularDystrophy wreck families. Even when there is no cure, families have consistent chosen definitive testing to solve the diagnosis, so they can end the doubts, end the endless years of clinical assessments, and plan for the remaining years. http://lnkd.in/q5xQ7H View in LinkedIn

NEGOTIATING SKILLS ARE CRITICAL fir entrepreneurs, as critical as the technical expertise you have for your innovative ideas. This article is another MUST READ from an experienced entrepreneur. http://lnkd.in/3CS3ck View in LinkedIn

CUMULATIVE PATENT VALUES IN THE US ARE VAST, equal to almost half the value of the GDP. This unusual article does a great job of surveying the landscape of players from IP brokers to litigators. Be aware that today, most IP of value will be challenged in court for obviousness or prior art. An important strategy is to send a patent draft to s good patent litigator in your field and asses the weaknesses in the application. This allows you to stress test the IP before you file it. IP is your most valuable asset. Invest in developing a thorough IP strategy going forward. http://lnkd.in/KZ6F9i View in LinkedIn

THE PHARMA IP LANDSCAPE AT A GLANCE, a useful summary. http://drugpatentwatch.com/innovation/ View in LinkedIn

GREAT ADVICE ABOUT STARTUP CULTURES. http://lnkd.in/wdeEkS View in LinkedIn